GBP Capital / Lentigen Corporation / Merck and Co. Inc. / /
Country
United States / /
Event
FDA Phase / /
Facility
UH MacDonald Women's Hospital / Children's Hospital / UH Case Medical Center / MetroHealth Medical Center / The Johns Hopkins University / University Hospitals Case Medical Center / National Cancer Institute / University Hospitals / Case Western Reserve University / Lentigen’s pipeline / Cleveland Clinic Lerner College of Medicine / Cleveland Clinic / University of Minnesota / Loyola University / Case Medical Center / The University of Pennsylvania / Louis Stokes Cleveland Department of Veterans Affairs Medical Center / The University of Pittsburgh / /
radiation therapy / neurosurgery / chemotherapy / surgery / radiation / gene therapy / cardiovascular surgery / /
Organization
Harvard Medical School / National Cancer Institute / UH MacDonald Women's Hospital / Louis Stokes Cleveland Department of Veterans Affairs Medical Center / Brain Tumor and Neuro-Oncology Center / The Johns Hopkins University / Case Western Reserve University School of Medicine Founded / Case Western Reserve University / The University of Pennsylvania / Cleveland Clinic Lerner College of Medicine / UH Case Medical Center / Ohio's Third Frontier Commission / Seidman Cancer Center / University of Pittsburgh / Loyola University Chicago / Center for Stem Cell & Regenerative Medicine / Case Western Reserve University School of Medicine / UH Rainbow Babies & Children's Hospital / MetroHealth Medical Center / University Hospitals Case Medical Center / University of Minnesota / /
Person
Andrew Sloan / Tim Ravenscroft / Stanton Gerson / /
Position
CEO / Director / Director of the Case Comprehensive Cancer Center / Associate Professor of Neurological Surgery and Pathology / /
Microsoft Word - Lentigen press release on Glioblastoma Phase I Initiation_Final_111114.doc